Retrotope (United States)
Retrotope, Inc. is a drug development company advancing the idea that polyunsaturated fatty acids drugs fortified with heavy isotopes protect living cells by making bonds within the delicate molecules inside and around cells harder to break. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Retrotope (United States), United States, covering academic research published from 2010 to 2023. Read More.
Open Access Percentage
51%
Total
Publications
80
Total Open
Publications
41
Total
Citations
5.6K
Open Access
Percentage
51%
Total
Publications
80
Total Open
Publications
41
Total
Citations
5.6K
Breakdown
Publisher Open
10%
Both
27%
Other Platform Open
12%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 55%
16
Hybrid 21%
6
No Guarantees 24%
7
Other Platform Open
Domain 83%
25
Institution 23%
7
Other Internet 20%
6
Preprint 7%
2
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 25 |
DOI | Other Internet | 6 |
University of Cambridge - Apollo | Institution | 4 |
Research Square | Preprint | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
Belarusian State University - BSU Digital Library | Institution | 2 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 1 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
Site cant be reached | Institution | 1 |
Nanyang Technological University - DR-NTU | Institution | 1 |